Emerging Clinical Diagnostics Laboratory – Built for Scale | $4–$5M Revenue Growth Potential
This is a rare opportunity to acquire a fully credentialed clinical medical laboratory in its early growth stage, strategically positioned to scale to $4–$5 million in annual revenue within the next 24 months under focused business development and payer expansion.
Importantly, this is not a startup — the lab is fully operational with infrastructure, licensing, equipment, and compliance foundations already in place. Replicating this build-out from scratch would conservatively exceed $4 million in capital investment, making this a true replacement-cost acquisition with substantial upside.
Business Overview
This clinical laboratory provides a wide range of diagnostic testing services used by healthcare providers to diagnose, monitor, and screen for health conditions. The lab is:
Registered with an active NPI (National Provider Identifier)
Operating under CLIA certification
Approved to perform regulated clinical laboratory testing
The platform is structured for expansion rather than stabilization, presenting a growth-oriented acquisition opportunity.
Services & Capabilities
The lab currently offers a broad testing menu, including:
Genetic and molecular diagnostics
Routine clinical testing
Clinical toxicology
Allergy testing
COVID-19 testing
Regulatory approvals allow testing across multiple disciplines, including:
Bacteriology
Clinical chemistry
Immunology (serology)
Endocrinology
Hematology
Toxicology
Urinalysis
Virology
This diversified testing capability supports scalability across multiple provider verticals.
Clinical Credentials
The laboratory team includes:
Board-certified pathologists
Ph.D.-level professionals in molecular diagnostics
Qualified clinical laboratory personnel
The lab emphasizes competitive turnaround times and flexible provider ordering/reporting systems, creating a scalable, provider-facing platform.
Location & Market
Located in Central New Jersey, servicing healthcare providers throughout New York and New Jersey — two of the most regulated and high-value healthcare markets in the country.
Growth Opportunity – Asset Sale
This lab is operationally early-stage but fully built structurally. Key growth drivers include:
Expansion of provider network
Increased specimen volume
Strategic payer contracting
Sales force deployment
Targeted specialty testing expansion
With proper capitalization and business development, the platform is positioned for significant near-term revenue growth.
Ideal Buyer
This opportunity is ideal for:
Strategic laboratory operators
Healthcare investors
Private equity groups
Physician groups seeking vertical integration
Healthcare consolidators
This is a confidential offering. Detailed financials, payer mix, equipment schedules, and regulatory documentation are available upon signed NDA.
